Teradyne (NASDAQ:TER – Get Free Report) had its target price hoisted by equities researchers at Robert W. Baird from $305.00 to $332.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price target suggests a potential upside of 12.31% from the stock’s previous close.
Other research analysts have also issued reports about the company. Wall Street Zen raised Teradyne from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. The Goldman Sachs Group lifted their target price on Teradyne from $230.00 to $300.00 and gave the company a “buy” rating in a research note on Tuesday, February 3rd. UBS Group raised their price target on Teradyne from $200.00 to $275.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Vertical Research downgraded Teradyne from a “buy” rating to a “hold” rating and set a $220.00 price objective for the company. in a research note on Friday, January 9th. Finally, TD Cowen reiterated a “buy” rating on shares of Teradyne in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $275.53.
Get Our Latest Research Report on TER
Teradyne Price Performance
Teradyne (NASDAQ:TER – Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.44. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $970.44 million. Teradyne had a return on equity of 22.68% and a net margin of 17.37%.The business’s revenue for the quarter was up 43.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.95 EPS. Equities research analysts anticipate that Teradyne will post 3.88 EPS for the current year.
Hedge Funds Weigh In On Teradyne
Several institutional investors have recently bought and sold shares of the business. Norges Bank bought a new stake in shares of Teradyne during the fourth quarter worth $398,777,000. Wellington Management Group LLP raised its stake in shares of Teradyne by 13,949.4% during the third quarter. Wellington Management Group LLP now owns 2,036,887 shares of the company’s stock worth $280,357,000 after buying an additional 2,022,389 shares during the last quarter. Federated Hermes Inc. boosted its stake in Teradyne by 79.7% in the second quarter. Federated Hermes Inc. now owns 3,785,067 shares of the company’s stock valued at $340,353,000 after acquiring an additional 1,679,215 shares during the last quarter. Amundi raised its position in shares of Teradyne by 255.3% during the 2nd quarter. Amundi now owns 1,812,001 shares of the company’s stock valued at $170,654,000 after acquiring an additional 1,302,025 shares during the last quarter. Finally, Aspex Management HK Ltd bought a new position in shares of Teradyne in the 4th quarter worth $199,723,000. Institutional investors own 99.77% of the company’s stock.
Teradyne Company Profile
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
Featured Articles
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
